Scotsman: Bad Day: Pfizer Investors

Posted on by Rob Lewis - Leave a comment

ITS shares fell 12 per cent in New York after the world’s biggest drugmaker surprised the market by abandoning the development of its leading experimental cholesterol treatment, torcetrapib.

Read the full article at Scotsman.com

Related posts:

  1. Scotsman: Home Loans And Retail Sales Charge Ahead MORTGAGE lending rose to its highest level in nearly three years last month, and UK retailers have enjoyed their strongest...
  2. Money Links For 17th Oct 2006 Links to other interesting money articles on 17th Oct 2006....
  3. Money Links For 8th Dec 2006 Links to other interesting money articles on 8th Dec 2006....
  4. Why New Breaks For First Time Buyers Won’t Work In another depressing read for us first-time buyers looking to get onto the property ladder, Peter Temple of Interactive Investor...
  5. Post Office Lifestyle Protection The Post Office has taken the brave move of getting into the much-maligned payment protection market....


Tagged

Leave a Comment

Your email address will not be published. Required fields are marked *